Assessment of the Role of Interstitial Glucagon in the Acute Glucose Secretory Responsiveness of In Situ Pancreatic β-Cells
Open Access
- 1 March 2002
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 51 (3) , 669-675
Abstract
Glucagon is a potent stimulator of insulin release in the presence of a permissive glucose concentration, activating β-cells in vitro via both glucagon- and glucagon-like peptide-1 (GLP-1)-receptors. It is still unclear whether locally released glucagon amplifies the secretory responsiveness of neighboring β-cells in the intact pancreas. The present study investigates this question in the perfused pancreas by examining the effects of antagonists for glucagon receptors ([des-His1,des-Phe6,Glu9]glucagon-NH2, 10 μmol/l) and GLP-1-receptors [exendin-(9-39)-NH2, 1 μmol/l] on the insulin secretory response to glucose. The specificity of both antagonists was demonstrated by their selective interaction with glucagon-receptor signaling in rat hepatocytes and GLP-1-receptor signaling in Chinese hamster lung (CHL) fibroblasts. In purified rat β-cells, the glucagon-receptor antagonist (10 μmol/l) inhibited the effect of 1 nmol/l glucagon upon glucose-induced insulin release by 78 ± 6%. In the perfused rat pancreas, neither of these antagonists inhibited the potent secretory response to 20 mmol/l glucose, although they effectively suppressed the potentiating effect of, respectively, an infusion of glucagon (1 nmol/l) or GLP-1 (1 nmol/l) on insulin release. When endogenous glucagon release was enhanced by isoproterenol (100 nmol/l), no amplification was seen in the simultaneous or subsequent insulin secretory response to glucose. It is concluded that, at least under the present selected conditions, the glucose-induced insulin release by the perfused rat pancreas seems to occur independent of an amplifying glucagon signal from neighboring α-cells.Keywords
This publication has 50 references indexed in Scilit:
- [des His1, des Phe6, Glu9]glucagon amide: A newly designed “pure” glucagon antagonistBioorganic & Medicinal Chemistry Letters, 1995
- Cefoperazone plus tobramycin versus ticarcillin plus tobramycin in febrile granulocytopenic cancer patientsThe American Journal of Medicine, 1988
- Purified Islet Cells in Diabetes ResearchHormone Research, 1986
- Circulating Somatostatin Acts on the Islets of Langerhans by Way of a Somatostatin-Poor CompartmentScience, 1982
- Functional differences between rat islets of ventral and dorsal pancreatic origin.Journal of Clinical Investigation, 1982
- A different action of hypothermia on insulin release from the isolated, perfused rat pancreas, depending on the stimulating agentDiabetes, 1980
- The incretin concept todayDiabetologia, 1979
- Immediate and Time-Dependent Effects of Glucose on Insulin Release from Rat Pancreatic TissueJournal of Clinical Investigation, 1978
- Pancreatic polypeptide and glucagon: Non-random distribution in pancreatic isletsLife Sciences, 1976
- FUNCTIONAL SUBDIVISION OF ISLETS OF LANGERHANS AND POSSIBLE ROLE OF D CELLSThe Lancet, 1975